[ad_1]
Scientists from Australia's Griffith and Adelaide Universities have developed a new blood test for early detection of early ovarian cancer and have for the first time identified a bacterial toxin that allows ovarian cancer to develop. to be followed by blood.
According to research, the new blood test revealed ovarian cancer with up to 90% accuracy of samples taken from people who had been infected at an early stage, and 100% of the samples taken from people in advanced stages.
"Early diagnosis of ovarian cancer at its early stages is relatively low and inaccurate, so many patients lose effective treatment if detection is delayed," the researchers said.
In addition to the full pelvic exam, doctors are currently following two methods of diagnosing the disease, namely ultrasound, the vaginal test and another test called "125 cancer antigen" in the blood. This test allows doctors to look for tumors in the uterus, the fallopian tubes and the ovaries, it reveals whether the growth is cancerous or not.
Antigen 125 levels can also increase in non-cancerous cases such as endometrial inflammation, pelvic inflammatory disease, hepatitis and hepatic cirrhosis.
** Learn more about euronews:
**
"Ovarian cancer is known to be difficult to detect in its early stages, when there are more options for treatment and survival," said Professor James Baton, chief of the Research team and director of the Center for Infectious Disease Research at Adelaide University. A potential change in the equation of cancer treatment. "
Researchers are now looking for more clinical trials on more blood samples, in hopes of improving the new test and making it eventually available to the public.
Source link
